iNtRON Biotechnology Inc

Bio Company listed on Korea stock market by passing technical evaluation iNtRON Biotechnology strives to be such a company which contributes to the national economy, takes social responsibility, makes dreams and hopes come true, maximizes the value of stocks, develops cutting edge technologies, has endless passions and finally respects Korea. iNtRON biotechnology will grow up to be a global company which develops Bio New Drug. iNtRON Biotechnology has set up the research reagent and the nucleic acid reagent business as a Cash Cow Business. From now, iNtRON will be a new winner at the molecular diagnosis field. At the same time, alternatives of chemical antibiotics based on bacteriophase and lysin will become another cash cow business. In addition, iNtRON will be on top of developing Bio New Drug such as Superbacteria treatment. At last, iNtRON will challenge to develop the artificial blood as a long term project.

- We have veen making contribution to public health by providing novel products for New flu, VRE Super Bacteria, food posisoning AI and etc.
- We have worked in co-operation with Korean major companies such as Samsung, LG and etc.

Founded 1999